Cancer and its treatments are well-recognized risk factors for venous thromboembolism (VTE).
Evidence suggests that the absolute risk depends on the tumor type, the stage or extent of …

PURPOSE To provide updated recommendations about prophylaxis and treatment of venous
thromboembolism (VTE) in patients with cancer. METHODS PubMed and the Cochrane …

Background Patients with active cancer have an increased risk of venous thromboembolism,
which results in substantial morbidity, mortality, and health care expenditures. The Khorana …

Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial events)
is highly consequential for patients with cancer and is associated with worsened survival. …

Background Patients with cancer have a substantial risk of recurrent thrombosis despite the
use of oral anticoagulant therapy. We compared the efficacy of a low-molecular-weight …

Importance Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC)
and request elective surgery or procedure present a common clinical situation yet …

Objective To evaluate the effects of therapeutic heparin compared with prophylactic heparin
among moderately ill patients with covid-19 admitted to hospital wards. Design Randomised …

Use of peripherally inserted central catheters (PICCs) has grown substantially in recent
years. Increasing use has led to the realization that PICCs are associated with important …

Importance Low-molecular-weight heparin is recommended over warfarin for the treatment
of acute venous thromboembolism (VTE) in patients with active cancer largely based on …